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Wednesday, March 4, 2009 599aperforming an energy minimization. Modeling of protein binding site flexibility
is still a challenging problem due to the large conformational space that must be
sampled and inaccurate energy function.
Here, we discuss a new strategy for achieving successful flexible docking of
peptides to PDZ domains. Due to promiscuous behavior of PDZ domain
proteins, two different sets of conformations are obtained by perturbing the
unbound structure along the normal modes of elastic network model (ENM) re-
sponsible for Class I and Class II type binding. A restrained replica exchange
molecular dynamics (REMD) is applied to these perturbed structures to explore
the conformational space of the protein receptor. After restrained-REMD,
different peptides are docked to each individual snapshots of the receptor to
generate a collection of docked complexes of different stabilities.
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Functional protein-protein interactions are essential for many physiological
processes. Some of these functional interactions have been hypothesized to
play a role in substrate channeling, cofactor or coenzyme transfer, and compart-
mentation in glycolysis as a result of transient or dynamic interactions between
glycolytic enzymes. Herein, Brownian dynamics (BD) elucidates the interac-
tions between the glycolytic enzymes glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) and lactate dehydrogenase (LDH); the transfer of the cofactor
nicotinamide adenine dinucleotide (NAD) between LDH and GAPDH. BD
tests the hypotheses of whether the interaction between GAPDH and LDH
produces a functional complex that can efficiently and reversibly transfer the
cofactor NAD(H) between both enzymes. Preliminary results suggest favorable
enzyme-enzyme complexes between GAPDH and LDH involving four differ-
ent binding modes. These complexes are mainly stabilized by positively
charged lysine residues and negatively charged glutamates and aspartates
from both GAPDH and LDH. The efficiency of transfer determined as the rel-
ative number of BD trajectories that reached any active site of LDH or
GAPDH, show higher transfer efficiencies (about an order of magnitude)
when the cofactor NAD is transferred from a GAPDH active site to an LDH
active site as compared to transfer efficiencies of NAD from solution to each
enzyme of the complex. The average transfer time of NAD from solution to
the free enzymes is 500 ns as compared to 57-200 ns when NAD is transferred
between active sites of a GAPDH/LDH complex. Similarly, the frequency
distribution profiles of transfer times suggest a preference for channeling
NAD between GAPDH and LDH as compared to diffusing from solution.
Channeling transfer is more efficient that solution transfer, due to active site
proximity, favorable electrostatics and complex geometry
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The ABC transporter superfamily is among the largest and most broadly ex-
pressed protein families. Members of this family use the energy stored in
ATP molecules to actively extrude a variety of substrates from cells, including
exogenous compounds such as drugs, metabolites, peptides, steroids, ions and
phospholipids. So far, the best known and characterized major drugs trans-
porters, have been studied in details with respect to their structure and function.
It has been showed that ATP-dependent transporters can cause resistance in
cancer cells by actively extruding the clinically relevant chemotherapic drugs.
There is accumulating evidence that active export of anticancer drugs from
cells by means of specific transporters is one of the major mechanism of
drug resistance. Camptothecin (CPT) and its derivatives has been proven to
be effective against a broad set of tumors. The CPT target is the human
DNA topoisomerase I, an enzyme that changes the topological state of the
DNA double helix during biological activity of the cell. Here we report a com-
putaional study of the interaction mechanism between a set of biochemically
and clinically relevant campthotecin ligands. A series of multiple docking
simulations were carried out using the topotecan, gimatecan and irinotecan
CPT derivatives as possible ligands, and a homology model of ABCG2 trans-
porter was used as target molecule. Our results show that the camptothecin
derivatives dock to distinct sites located in the trans-membrane region of the
transporter molecule. The chemical nature of the substitutions at position A
of the CPT analogues used in this study is also analyzed to identify the struc-
tural prerequisites responsible for the relative selectivity of the ligand.The structural basis of ligand binding may help design new CPT analogues
with reduced side effects and higher affinity.
Protein-Ligand Interactions III
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The Catalytic-subunit of Protein Kinase A (PKAc) mediates the phosphoryla-
tion of a number of proteins in cardiomyocytes which, in turn, governs myocar-
dial contraction and relaxation. Although a wealth of kinetic and atomic-level
structural data is available for the interactions of PKAc with standard, largely
non-physiologically relevant substrates, these data are nearly absent for the
interactions with substrates found in cardiomyocytes. Phospholamban (PLN)
is a substrate of PKAc in cardiomyocytes, where it regulates the sarcoplasmic
reticulum Ca25ATPase. Phosphorylation of PLN allows the relief of its inhib-
itory affects on Ca2þ transport into the sarcoplasmic reticulum. Here, we
investigate the interactions of PKAc with PLN using a variety of biophysical
techniques which include NMR spectroscopy, isothermal calorimetry (ITC),
and steady-state kinetic assays. Kinetic assays were used to define the
steady-state kinetic parameters for the catalytic efficiency of phosphorylating
PLN and two mutants of PLN, R9C and R14-delete. The ability of PKAc to
bind these proteins was also measured using ITC to investigate any differences
in binding affinity. Finally, TROSY-based NMR spectroscopy was used to
observe and map the residue specific differences in the amide fingerprint of
PKA-C when bound to each of these substrates. These data will be presented
to model the effects of PLN mutations on the interactions with PKAc.
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Many cell-surface proteins are glycosylated, and the carbohydrates moieties
can play important roles in the biological function of these proteins. Computa-
tional models have proven to be highly successful in providing deep insights
into the functions of proteins and nucleic acids, and thus the application of sim-
ilar approaches to the functional interactions of glycoproteins is promising area
of research.
We have developed several new approaches to the modeling of interactions
between glycoproteins, including continuum solvation models optimized for
carbohydrates, and adaptions of computational protein design algorithms for
application to glycoproteins. Results in simple systems show that these
methods are highly efficient and robust [Green, DF, J. Chem. Phys. 2008].
Our new methods have additionally been applied to understanding the key fea-
tures of carbohydrate recognition by virucidal lectins that are currently under
investigation as anti-HIV prophylatics. Computional models explain the oligo-
saccharide specificity of cyanovirin-N, [Fujimoto, YK et al., Protein Sci. 2008]
and initial results in the design of cyanovirin-N variants with enhanced efficacy
are very promising.
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Centrin is an EF-hand protein that plays both structural and regulatory roles in
the centrosome. FT-IR spectroscopy was used to study Hcen1 and Hcen2 in the
spectral region of 1700 - 1530 cm1 was studied to determine the order of
events during the thermal perturbation. For Hcen1 the order of events through-
out the thermal perturbation is detailed as the following: alpha-helix followed
by beta-sheets then glutamate and finally beta-turns while for Hcen2 the order
of events: 310-helix followed by aggregation then b-turns, arginine and finally
loops. A higher thermal stability was observed for Hcen1 than for Hcen2 and
a pre-transition at 1.7 - 4.8 C and the onset of the transition temperature
was also observed for Hcen1 at 80.5 - 84 C. Unlike Hcen1, Hcen2 was
observed to aggregate at the temperature range of 43 - 58 C. Therefore, we
were able to establish differences in stability, conformation and dynamics
between these closely related calcium binding proteins.
Furthermore, this calcium-binding protein interacts at low calcium levels with
a novel 1242-amino acid protein known as Sfi1, which contains up to 23 cen-
trin-binding sites. Coupled biophysical, structural, and dynamic analyses of the
centrin/Sfi1 complex are essential to the understanding of its biological func-
tion. Using an interdisciplinary approach we have determined the
600a Wednesday, March 4, 2009conformational changes involved in the centrin-Sfi1p21 complex formation by
FT-IR spectroscopy, two dimensional correlation spectroscopy and isothermal
titration calorimetry. The binding was exothermic and the thermodynamic data
for Hcen1-Sfi1p21 was the following: N 1.335 0.0165, Ka 1.59 x10
75 2.48
x106 M, DH 1.72 x1045 301.1 kcal/mol and DS 23.8 kcal/mol. We have
also established the relative stability of these proteins by differential scanning
calorimetry. Our experiments address key questions underlying the molecular
basis of this complex interaction.
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Background: Pharmaceutical blockade of the platelet aIIbb3 integrin receptor
has reduced mortality from cardiovascular disease. However, gaps in mecha-
nistic understanding limit clinical efficacy and delay new drug development.
Objectives: Integrating surface plasmon resonance (SPR) and dynamic force
spectroscopy (DFS), we aim tomeasure the strength of integrin:ligand bonds, de-
termining their weakest link and identifying new therapeutic intervention routes.
Methods: cHarGD, a cyclic peptide structurally similar to eptifibatide, a widely
used antiplatelet drug, served as a model ligand, one readily coupled to biosen-
sors and AFM tips. SPR provided kinetic, equilibrium, and transition state ther-
modynamic parameters for aIIbb3:cHarGD complex formation, while DFS
measured their mechanical stability. cHarGA, lacking the aspartate required
aIIbb3 binding, served as a negative control.
Results: SPR demonstrated that integrin binding to immobilized cHarGD was
rapid (kon ~ 7  103 L/mol-sec at 25 oC), readily reversible (koff ~ 102 sec1),
and specific (100-fold smaller signals with cHarGA). Eyring and van’t Hoff
analyses indicated that after overcoming an entropic barrier (DGa
oz 12 kcal/
mol), both enthalpy and entropy favored assembly of the aIIbb3:cHarGD com-
plex (DG - 8 kcal/mol). Preliminary DFS experiments (12 nN/sec loading rate)
indicated that the rupture force of cHarGD:aIIbb3 is about 300 pN. In control
experiments, where the tip was functionalized with cHarGA or albumin, lower
rupture forces of 225 pN and 170 pN were observed.
Conclusions:Our SPR data indicate that entropy plays amajor role in target rec-
ognition by integrin antagonists, a property shared by ~25% of drug:receptor in-
teractions. Our DFS data suggest that integrin:ligand interactions are stabilized
by multivalent contacts between clustered receptors and pharmaceutical inhib-
itors.This studywill provide the first complete picture of the landscape for integ-
rin:ligand interactions, using temperature and force as thermodynamic variables
to determine the energetics and nm scale on which bond disruption occurs.
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Liver Fatty Acid Binding Protein (L-FABP), a small (14 kDa) abundant cytosolic
protein, may perform several functions in cells, including intracellular transport
of fatty acids, nuclear signaling, and regulation of intracellular lipolysis. Among
the members of the intracellular lipid binding protein (iLBP) family, L-FABP is
very unique in its ability to bind two molecules of FA and a variety of other bulky
ligands such as bilirubin. To help understand the promiscuous binding and trans-
port properties of L-FABP, we have applied multi-dimensional homonuclear and
heteronuclear NMR spectroscopy for studies of its structure and ligand binding.
The overall conformation of human L-FABP, as determined from NOE-derived
distance restraints, shows a b-clammotif comprised of a 10-stranded anti-parallel
b-sheet that is covered by 2 short nearly parallel a-helices. Ligand binding to L-
FABP is being studied by NMR titration experiments with two types of ligands.
In the case of oleic acid, which is the primary physiological ligand of L-FABP,
2D HSQC spectra with different binding stoichiometries showed two binding
sites with different affinities. In addition, two 13C-labeled bilirubin analogs
are being studied to assess binding of bulky ligands. We hypothesize that the
unique binding of bulky hydrophobic ligands enables the L-FABP to undergo
a conformational change that is different from the other FABPs.
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Splicing Factor 1 (SF1) and U2 snRNP auxiliary factor (U2AF65) form an
essential protein complex that recognizes the 30 splice site during the initialstages of pre-mRNA splicing. A ~100 amino acid domain of SF1 located be-
tween an N-terminal region that is necessary and sufficient U2AF65-interac-
tions, and a C-terminal RNA-binding domain. Despite high sequence conserva-
tion from yeast to mammals, the structure and function of this SF1 ‘mystery’
domain is currently unknown. Here, we demonstrate that the SF1 ‘mystery’
domain participates in the SF1 / U2AF65 interface by comparing heat capacity
changes and chemical shift differences for U2AF65 association with deletion
variants of SF1. Heat capacity changes for association of SF1 with the
U2AF65 interacting domain (UHM) are significantly greater than those
observed for association with a SF1 peptide composed of the minimal
U2AF65-interacting region. In contrast, the heat capacity changes for SF1 pep-
tide/U2AF65UHM association closely matched those predicted from the buried
surface area of the complex. Given that heat capacity changes often correlate
with the amount of surface area buried by complex formation, one possible ex-
planation for this difference was that additional regions of SF1 participate in the
U2AF65UHM interface. To investigate this possibility, the HSQC spectra of
15N-labeled U2AF65-UHM in complex with SF1 C-terminal deletion variants
were compared. Chemical shift differences imply that residues from conserved
‘mystery’ domain of SF1 participate in the U2AF65UHM interface. The influ-
ence of this SF1 domain on affinity and cooperativity of pre-mRNA recognition
by the SF1 / U2AF65 is further investigated by calorimetry and fluorescence an-
isotropy. These studies aid in elucidating the structural and thermodynamic
means for 30 splice site recognition by the essential SF1 and U2AF65 complex.
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We have studied a human delta-opioid receptor interacting with two agonists,
Clozapine and Desmethylclozapine. Delta-opioid receptors belong to the fam-
ily of G protein-coupled receptors, that transduce an intracellular biological sig-
nal upon activation via interaction with a ligand in the transmembrane domain.
Although Clozapine and Desmethylclozapine only differ by a methyl group,
experimental data have evidenced a more efficient action of Desmethylcloza-
pine in the treatment of refractory schizophrenia. A molecular analysis may
help to clarify issues related this difference. Molecular Dynamics simulations
help to elucidate the microscopic mechanism of the interactions between the
ligand and the receptor identifying features barely seen in experiments. How-
ever, as in our case, the time scale of the processes of interest is often too
long to be approached by standard MD techniques. Thus, for our study we
have used a recent technique, the metadynamics, that accelerates MD runs ex-
tending simulation times. Our results pointed out different routes of the drugs
inside the receptor: Clozapine touches a larger number of competing minima
far from the putative receptor active zone than Desmethylclozapine. This latter
spends most of its time inside the receptor close to the residues of the active
zone, inducing noticeable structural modifications. Additionally, the simulation
of the entrance has provided evidence of a stronger interaction with the receptor
of Desmethylclozapine than Clozapine, resulting in a more frequent entrance of
the former. Clozapine exhibits a preferential interaction with the membrane be-
cause of its enhanced hydrophobicity. The free energy surfaces extracted from
the simulations have been used for kinetic Monte Carlo simulations to obtain
reliable residence times of the drugs inside the receptor. The whole results helps
to understand how microscopic details can remarkably affect efficiency and
activity of compounds, supporting the idea of a bottom-up strategy in the
drug design.
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Angiogenesis is a cellular process that involves the sprouting of new blood ves-
sels from pre-existing ones. Fibroblast growth factors (FGFs) play a crucial role
in the regulation for angiogenesis and tumor metastases. Therefore, intensive
research efforts are on to develop drugs that can specifically inhibit FGF-
induced angiogenesis. FGFs exhibit their cell proliferation activity by binding
to the extracellular D2 domain of their cell surface receptor. Suramin has been
previously shown to inhibit FGF-induced tumors. In this context, in the present
study, we investigate the interaction of suramin with the extracellular D2 do-
main of the FGF receptor (FGFR). Results of the isothermal titration calorim-
etry (ITC) experiments suggest that suramin binds to the D2 domain of FGFR
with a reasonably high affinity (Kd ~ 10
6 M). ITC experiments, carried out at
various salt concentrations, show that suramin-D2 domain interaction is mostly
stabilized by ionic interactions. Limited trypsin digestion experiments and
ANS binding experiments reveal conformational changes in the D2 domain
